Immunotherapy of cancer with lymphokine-activated killer cells and recombinant interleukin-2

scientific article published on 01 September 1985

Immunotherapy of cancer with lymphokine-activated killer cells and recombinant interleukin-2 is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID3898451

P50authorSteven RosenbergQ2347448
P2093author name stringMulé JJ
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectimmunotherapyQ1427096
P304page(s)437-444
P577publication date1985-09-01
P1433published inSurgeryQ15731526
P1476titleImmunotherapy of cancer with lymphokine-activated killer cells and recombinant interleukin-2
P478volume98

Reverse relations

cites work (P2860)
Q41149412Cytotoxic effects of tumour necrosis factor and gamma-interferon on acute myeloid leukaemia blasts
Q45260708In vivo boosting of lung natural killer and lymphokine-activated killer cell activity by interleukin-2: comparison of systemic, intrapleural and inhalation routes
Q87473745Novel TNF-related Apoptotic-inducing Ligand-based Immunotoxin for Therapeutic Targeting of CD25 Positive Leukemia
Q39737942The adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukin-2.
Q38148745The intersection of immune-directed and molecularly targeted therapy in advanced melanoma: where we have been, are, and will be.

Search more.